Office Action Predictor
Application No. 17/585,199

HEART FAILURE DIAGNOSTIC DEVICE

Final Rejection §101§112
Filed
Jan 26, 2022
Examiner
SHAH, JAY B
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Osaka University
OA Round
2 (Final)
56%
Grant Probability
Moderate
3-4
OA Rounds
3y 6m
To Grant
58%
With Interview

Examiner Intelligence

56%
Career Allow Rate
204 granted / 363 resolved
Without
With
+1.9%
Interview Lift
avg trend
3y 6m
Avg Prosecution
39 pending
402
Total Applications
career history

Statute-Specific Performance

§101
17.6%
-22.4% vs TC avg
§103
34.7%
-5.3% vs TC avg
§102
12.9%
-27.1% vs TC avg
§112
28.4%
-11.6% vs TC avg
Black line = Tech Center average estimate • Based on career data

Office Action

§101 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of Claims The amendment filed 6/13/26 is acknowledged. Claims 1-5 are pending. Claim 5 is new. Claim 1 and 4 are amended. Claim Rejections - 35 USC § 112 Claim 1-5 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 (the rest by dependency) recites “an indicator”, “a previous indicator value” and then recites “the indicator value derived from a standard deviation of a respiratory frequency…”. It is unclear if the limitation “the indicator value derived from a standard deviation of a respiratory frequency…” only applies to the initial recitation of “an indicator” or if “a previous indicator value” was also previously derived from a standard deviation of a respiratory frequency. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. Claims 1-5 rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea without significantly more. The claim(s) recite(s) comparing an indicator value with a predetermined value or a previous indicator value, the indicator value derived from a standard deviation of a respiratory frequency; obtaining a power spectrum; correcting a detection signal such that in the power spectrum, a maximum value of a first-order frequency component of a respiratory waveform is not smaller than 1.5 times a maximum value of a second-order frequency component of the respiratory waveform a. The abstract idea is part of the Mathematical Concepts group(s) identified in the Ninth Edition, Revision 10.2019 (revised June 2020) of the Manual of Patent Examination Procedure (MPEP). This judicial exception is not integrated into a practical application because they amount to simply implementing the abstract idea on a computer; data-gathering steps do not add a meaningful limitation to the method as they are insignificant extra-solution activity; there is no improvement to a computer or other technology; does not apply the abstract idea to effect a particular treatment or prophylaxis for a disease or medical condition; does not apply the abstract idea with, or by use of, a particular machine. The additional elements are identified as follows: a piezoelectric sensor and a processor. The claim(s) does/do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the additional elements, when considered both individually and as a whole, do not amount to significantly more than the abstract idea. The additional computer and data-gathering elements, which are recited at a high level of generality, provide conventional computer and data-gathering functions that do not add meaningful limitations to practicing the abstract idea. Those in the relevant field of art would recognize the above-identified additional elements as being well-understood, routine, and conventional means for data-gathering and computing, as demonstrated by Vaschillo et al. (The effects of sighing on the cardiovascular system; 2015). Thus, the claimed additional elements “are so well-known that they do not need to be described in detail in a patent application to satisfy 35 U.S.C. § 112(a).” Berkheimer Memorandum, III. A. 3. When considered in combination, the additional elements (generic computer functions and conventional equipment/steps) do not amount to significantly more than the abstract idea. The Federal Circuit has held that combining additional elements for data-gathering with abstract ideas does not make a claim patent-eligible. Looking at the claim limitations as a whole adds nothing that is not already present when looking at the elements taken individually. There is no indication that the combination of elements improves the functioning of a computer or improves any other technology. Their collective functions merely provide conventional computer implementation. Regarding the dependent claims, the dependent claims are directed to either 1) steps that are also abstract or 2) additional data gathering that is well-understood, routine and previously known to the industry. Although the dependent claims are further limiting, they do not recite significantly more than the abstract idea. A narrow abstract idea is still an abstract idea and an abstract idea with additional well-known data-gathering equipment/functions is not significantly more than the abstract idea. Response to Amendment and Arguments Regarding 112F interpretations, Applicant’s amendments have been fully considered. The claims are no longer interpreted under 112F. Regarding 112B Rejections, Applicant’s amendments have been fully considered. The prior rejections are withdrawn. Additional rejections are presented. Regarding prior art rejections, Applicant’s amendments have been fully considered and the rejection is withdrawn. However, Examiner notes that Applicant has amended the claims to positively recite correcting a signal and also positively recite comparing an indicator derived from a standard deviation of respiratory frequency to a previous indictor or a predetermined value. This represents an abstract idea, and thus a 101 rejection is presented. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAY B SHAH whose telephone number is (571)272-0686. The examiner can normally be reached M-F 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at 571-272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. JAY SHAH Primary Examiner Art Unit 3791 /JAY B SHAH/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Jan 26, 2022
Application Filed
Mar 08, 2025
Non-Final Rejection — §101, §112
Jun 13, 2025
Response Filed
Sep 30, 2025
Final Rejection — §101, §112
Apr 04, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology. Study what changed to get past this examiner.

Patent 12594389
NON-INVASIVE ESTIMATION OF HEMODYNAMIC PARAMETERS DURING MECHANICAL VENTILATION
2y 5m to grant Granted Apr 07, 2026
Patent 12594009
SYSTEM FOR SCREENING AND DIAGNOSIS OF DIABETES
2y 5m to grant Granted Apr 07, 2026
Patent 12588832
A MODULAR MOUTHPIECE
2y 5m to grant Granted Mar 31, 2026
Patent 12565175
METHOD AND SYSTEM FOR DETERMINATION AND CLASSIFICATION OF INTOXICATING SUBSTANCE IN A BREATH SAMPLE FACILITATED BY A USER INTERACTION SCHEME
2y 5m to grant Granted Mar 03, 2026
Patent 12551111
METHOD AND SYSTEM FOR DYNAMIC PHYSIOLOGICAL CHARACTERISTIC REGION CAPTURING
2y 5m to grant Granted Feb 17, 2026

AI Strategy Recommendation

Click below to generate an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
56%
Grant Probability
58%
With Interview (+1.9%)
3y 6m
Median Time to Grant
Moderate
PTA Risk
Based on 363 resolved cases by this examiner